Increased Expression of Circulating microRNA 101-3p in Type 1 Diabetes Patients: New Insights Into miRNA-Regulated Pathophysiological Pathways for Type 1 Diabetes
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.01637
Full Text
Open PDFAbstract
Available in full text
Date
July 23, 2019
Authors
Publisher
Frontiers Media SA